Retatrutide, a novel compound , is sparking considerable excitement within the weight management arena . This drug combines the actions of dual GLP-1 hormone stimulators, semaglutide , and seems exhibiting remarkable efficacy in patient studies . Early data suggest this treatment may enable larger body loss than currently therapies, potentially off